School Of Medicine Basic Sciences

Combining deep mutagenesis and cryo-EM reveals new conformational state of a protein responsible for high-speed DNA replication. The research builds on growing theories of molecular evolution. Read More

Mohammed AlQuraishi, assistant professor at Columbia University, will give an Apex Lecture on Monday, Jan. 29, at 12:00 p.m. CT in 214 Light Hall. His talk, “The State of Protein Structure Prediction and Friends,” is hosted by the School of Medicine Basic Sciences and co-sponsored by the Center for Applied AI in Protein Dynamics. Read More

Avenir Award funding from the National Institute on Drug Abuse recognizes research that represents “the future of addiction science.” Brown’s research is creating an AI-experiment feedback loop that will help optimize painkilling drugs to be less addictive. Read More

Join the next Lab-to-Table conversation, “Beyond Addiction: Therapeutic Developments and Societal Impact” on Jan. 24 at 11:30 a.m. CT. Read More

The School of Medicine Basic Sciences and the Office of the Vice Provost for Research and Innovation launch the Innovation Ignition Fund. This pilot program offers up to $500,000 in funding and drug development mentorship from Vanderbilt scientists with expertise in translational research. Read More

Vanderbilt researchers, in collaboration with investigators from the University of Alabama at Birmingham, the Delft University of Technology, University Hospital Bonn, and Molecular Horizon have developed new protocols to study which molecular pathways might be important in the aging retina and what might cause the formation of deposits in the eye that confer high risk for age-related macular degeneration. Read More

As a Marshall Scholar, considered among the most accomplished undergraduates and recent graduates in the U.S., Neikirk will pursue advanced degrees in social determinants of health and biomedical imaging. Read More

In just over two years, a Vanderbilt-Neumora collaboration has led to the Phase 1 clinical trial of a treatment for schizophrenia spectrum disorders, which affect 3.7 million adults in the United States. This is the third chemical compound discovered at the Warren Center for Neuroscience Drug Discovery to reach Phase 1 clinical trials.     Read More

By Jenna Somers Heidi Carlone A three-year, nearly $1.3 million grant from the National Science Foundation supports a trans-institutional research team at Vanderbilt University investigating an innovative approach to STEM education that could help young people develop STEM identities and agency amid climate anxiety. Children around the world… Read More

As a professor of biochemistry and medicine at Vanderbilt University School of Medicine for more than 40 years, Osheroff is the longest serving course director currently teaching medical students. He also codirects the preclerkship phase of the medical school curriculum and leads the Master Science Teachers cohort, a role established in 2007 to recognize VUSM’s outstanding basic science educators. Through his teaching, he has helped medical students at VUSM and across the globe acquire the basic science skills and knowledge they need to thrive in clinical practice, according to the AAMC. Read More

New research from the Office of Biomedical Research Education and Training connects the dots between career goals during graduate school and career outcomes, articulates how careers of Ph.D. alumni evolve during the 10 years after graduation. Read More

School of Medicine Basic Sciences researchers at the forefront of Charcot-Marie-Tooth disease research and therapeutic development join CTTC leadership at CMT Research Foundation global research convention. The CMTRF has invested in further research at Vanderbilt to address the primary genetic cause of disease in patients with CMT disease type 1A. Read More

Trans-institutional project connects Vanderbilt experts in drug delivery, stem cell engineering, biomanufacturing and cell biology to advance biomanufacturing of nanoparticles that can deliver precisely targeted drugs to the site of a disease. Read More

Join “Coffee: Where Science Meets Sips” in the next Lab-to-Table Conversation on Sept. 27. Read More

Vanderbilt Center for Addiction Research Associate Director Erin Calipari, with funding from the National Institute on Alcohol Abuse and Alcoholism, will investigate what happens in the brain that makes individuals return to drinking after periods of abstinence. Read More

Co-sponsored by the Department of Pharmacology & The Center for Applied Artificial Intelligence in Protein Dynamics, this session of the School of Basic Medicine's Apex Lecture Series features computational biologist Ivet Bahar, Ph.D. Read More

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a three-year grant to support research led by Houra Merrikh, PhD, professor of Biochemistry, and Ben Ho Park, MD, PhD, the Benjamin F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, to create an anti-evolution drug to reduce the capacity of cancer cells to develop resistance. Read More

Experts in research on Alzheimer’s disease and related dementias share their latest findings at the 2023 Alzheimer’s Association International Conference. Nik Lampe, postdoctoral researcher, was awarded a grant to examine the social and medical factors influencing ADRD using data from VUSNAPS. Read More